GIL 2014: Europe

Published: 3-Apr-2014

14 May 2014

Annual Congress

Royal Garden Hotel, London, UK


New trends in the healthcare industry will be examined at Frost & Sullivan's annual congress, GIL 2014: Europe, with a focus on the key market drivers in Europe and beyond over the next few years.

According to Frost & Sullivan, there is an urgent need for affordable, yet sustainable innovation, or 'frugal innovation'.

Highlights will include: The New Mega Trends - Macro to Micro Opportunities for Future Business, Cultures, and Personal Lives by Partner Sarwant Singh; Global Smart City Market – A $1.5 trillion Market Opportunity by 2020; Industry Convergence Trends and Workshop; Exploring the Vortex of Innovation Driving New Concepts, Products and Services; and the 2014 Frost & Sullivan Growth Excellence Awards Banquet.

Organiser: Frost & Sullivan

gil-events.gilcommunity.com

Trending Articles

  1. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  2. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany
  3. Interphex 16-18 April 2024 | Conference and Exhibition | New York, US
  4. Making Pharmaceuticals 23–24 April 2024 | Exhibition | Coventry, UK
  5. CPhI Middle East 10–12 December 2024 | Conference | Riyadh, Saudi Arabia

You may also like

Research & Development

NGS providers prepare for growing Exome and RNA sequencing demand

New research from Frost & Sullivan’s Life Sciences Growth Partnership programme, analyses the European NGS services market potential, providing insights on key trends, drivers and implications, forecasting to 2023
Media

Cardiac therapies catalysed by next-gen technology

Strong product pipeline will drive double-digit growth rates in the Western Europe and US markets, finds Frost & Sullivan’s Transformational Health team
Media

Frost and Sullivan survey possible new Next Generation Sequencing markets

Sequencing platform providers aim to develop tests for infectious diseases, particularly meningitis and respiratory diseases
Media

Thriving healthcare markets in Asia and Latin America offer strong growth opportunities for global players

Growth in these emerging regions will dwarf the markets in Europe and Japan by 2025, finds Frost & Sullivan’s Transformational Health team
Media

Regenerative medicine research is attracting substantial public and private funding

Global synergies among diverse entities are broadening applications and helping to create growth opportunities and common standards, finds Frost & Sullivan
Media

India's standing in the biotechnology industry is driving rapid growth opportunities, finds report

Frost & Sullivan white paper discusses government incentives and investments leading the transition to a bio-economy
Media

Drive to increase local drug manufacturing presents opportunities for Ethiopian pharmaceuticals

Government offers tax incentives to increase in-country production of medicines and improve healthcare, finds report by Frost & Sullivan
Subscribe now